Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06709534 · ClinicalTrials.gov registry record · NA

An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors

A NA study of Malignant Female Reproductive System Neoplasm, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
4
Study locations

NCT06709534: Recruiting NA study of Malignant Female Reproductive System Neoplasm, sponsored by Emory University.

NCT06709534 is a NA study of Malignant Female Reproductive System Neoplasm that is actively recruiting participants, run by Emory University. The registered enrollment target is 40 participants, below the 402-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06709534, a NA study of Malignant Female Reproductive System Neoplasm, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
4
Study locations

Study Summary

This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digestive system) and symptoms such as pain, fatigue, sleep disturbance, depression, and cognitive impairment. These symptoms can significantly reduce the quality of life (QoL) and survival rate in this cancer population. Thus, promoting physical activity among cancer survivors may help mitigate these severe symptoms. Using online platforms such as Zoom can help participants access an individualized exercise program that meets their specific needs to engage in physical activity and decrease their symptom burden. Home-based exercise, by providing self-chosen time and location and low costs, can address some barriers to physical activity for cancer survivors. An individualized online home-based exercise program may be feasible, and may improve symptoms and quality of life in gynecologic cancer survivors.

Primary Outcome

Feasibility will be assessed by calculating attrition and adherence rates, identifying reasons for refusal, and evaluating the completeness of the data. We will consider the intervention to have low attrition and high adherence if \>80% of participants remain enrolled and complete the study, respectively.

Conditions Studied

Malignant Female Reproductive System Neoplasm

Interventions

  • OTHER Questionnaire Administration
  • OTHER Exercise Intervention
  • OTHER Functional Assessment
  • OTHER Medical Device Usage and Evaluation
  • OTHER Supportive Care

Study Locations (4)

Georgia

  • Grady Health System - Atlanta
  • Emory University Hospital Midtown - Atlanta
  • Emory University Hospital/Winship Cancer Institute - Atlanta
  • Emory Decatur Hospital - Decatur

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-01
Est. Completion 2027-07-30
Phase NA
Emory University

1,208 total trials

What NCT06709534 shows while recruiting

NCT06709534 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 402-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Malignant Female Reproductive System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT06709534 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06709534 about?

NCT06709534 is a clinical study titled "An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors". This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digestive system) and symptoms such as pain, fatigue, sleep disturbance, depression, and cognitive impairm...

What is the current status of trial NCT06709534?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-01. Estimated completion is 2027-07-30.

What conditions does trial NCT06709534 study?

This clinical trial studies the following conditions: Malignant Female Reproductive System Neoplasm.

What interventions are being tested in trial NCT06709534?

The interventions under investigation include: Questionnaire Administration (OTHER), Exercise Intervention (OTHER), Functional Assessment (OTHER), Medical Device Usage and Evaluation (OTHER), Supportive Care (OTHER).

Who is sponsoring clinical trial NCT06709534?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06709534 being conducted?

This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Female Reproductive System Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06709534's enrollment target sits among peer trials

40 13th of 18 higher than 6 of 18 other Malignant Female Reproductive System Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Female Reproductive System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06709534

Source: ClinicalTrials.gov NCT06709534, the US trial registry maintained by the National Library of Medicine. NCT06709534 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.